North America Nutraceutical Excipients Market
Tamanho do mercado em biliões de dólares
CAGR :
% 
 Período de previsão |
2023 –2030 |
 Tamanho do mercado (ano base ) | |
 Tamanho do mercado ( Ano de previsão) | USD 2,268.88 |
 CAGR |
% |
| Principais participantes do mercado |
>Mercado de excipientes nutracêuticos da América do Norte, por tipo (agentes aromatizantes, agentes corantes, adoçantes, agente de revestimento, tampões, solventes, transportadores, antiespumantes, agentes deslizantes, agentes humectantes, espessantes/agentes gelificantes, conservantes, ligantes, desintegrantes, lubrificantes , enchimentos e diluentes e Outros), Produto Final (Prebióticos, Probióticos , Suplementos de Proteínas e Aminoácidos, Suplementos Minerais, Suplementos Vitamínicos, Suplementos de Ómega-3 e Outros Suplementos), Forma (Seca e Líquida), Fonte de Excipiente (Natural e Sintético), Canal de Distribuição ( Direct Competition, Retail Sales e Outros) - Tendências e Previsões do Sector para 2030.
Análise e dimensão do mercado de excipientes nutracêuticos da América do Norte
Os excipientes nutracêuticos desempenham um papel importante na formulação de fármacos e no seu desenvolvimento. Estas substâncias envolvem substâncias diferentes do fármaco ou pró-fármaco farmacologicamente activo. Os excipientes nutracêuticos proporcionam ao fármaco uma entrega eficiente ao local alvo. Estas moléculas impedem que o medicamento seja libertado demasiado cedo durante a assimilação e aumentam a eficácia do medicamento. Alguns excipientes nutracêuticos promovem a integração do medicamento, o que aumenta a absorção do medicamento na corrente sanguínea.
A Data Bridge Market Research analisa que o mercado norte-americano de excipientes nutracêuticos deverá atingir o valor de 2.268,88 milhões de dólares até 2030, com um CAGR de 8,0% durante o período de previsão. Os fichários representam o maior segmento do mercado devido à rápida procura global. Este relatório de mercado também abrange análises de preços, análises de patentes e avanços tecnológicos em profundidade.
|
Métrica de reporte |
Detalhes |
|
Período de previsão |
2023 a 2030 |
|
Ano base |
2022 |
|
Anos históricos |
2021 (personalizável para 2020-2015) |
|
Unidades Quantitativas |
Receita em milhões de dólares, volumes em unidades, preços em dólares |
|
Segmentos cobertos |
Por Tipo (Aromatizantes, Corantes, Adoçantes , Agentes de Revestimento, Tampões, Solventes, Transportadores, Antiespumantes, Agentes Deslizantes, Agentes Molhantes, Espessantes/Agentes Gelificantes, Conservantes, Aglutinantes, Desintegrantes, Lubrificantes, Enchimentos e Diluentes e Outros), Produto Final ( Prebióticos, Probióticos, Suplementos de Proteínas e Aminoácidos, Suplementos Minerais , Suplementos Vitamínicos, Suplementos de Ómega-3 e Outros Suplementos), Forma (Seca e Líquida), Fonte de Excipientes (Naturais e Sintéticos), Canal de Distribuição (Concurso Directo, Vendas no Retalho e Outros) |
|
Países abrangidos |
EUA, Canadá, México |
|
Participantes do mercado abrangidos |
BASF SE., DuPont, Ingredion Incorporated, WR Grace and Co, Kerry Group, Sensient Technologies, Roquette Pharma Solutions, Cargill, Ashland. SEPPIC, Gatefosse, Pioma Chemicals, Omya., Gangwal Chemicals Private Limited, Grain Processing Corporation, IMCD Group., JRS Pharma LP, Azelis, Jigs Chemical, Sigaichi Industries, Beneo e Abitec, entre outros. |
Definição de mercado
Os excipientes nutracêuticos envolvem tudo num só medicamento, exceto os ingredientes nutracêuticos ativos. Estas moléculas não possuem propriedades medicinais e são utilizadas para melhorar a absorção fisiológica do fármaco. Os excipientes nutracêuticos são de natureza inerte, permitindo que a molécula do medicamento seja aplicada aos doentes na forma correta. Tradicionalmente, os excipientes nutracêuticos eram moléculas simples, mas a inovação tecnológica e a crescente procura por novos sistemas de administração de fármacos aumentaram a complexidade dos excipientes nutracêuticos. Os excipientes nutracêuticos promovem a aceitabilidade do medicamento pelo doente e aumentam a estabilidade e biodisponibilidade do medicamento.
O futuro da ciência e da tecnologia dos excipientes mudou e continua a mudar. Foram alcançados melhores progressos em áreas como a harmonização de monografias de excipientes e a aplicação de novos métodos analíticos para melhor caracterizar os excipientes.
Dinâmica do mercado norte-americano de excipientes nutracêuticos
Esta secção trata da compreensão dos impulsionadores do mercado, vantagens, oportunidades, restrições e desafios. Tudo isto é discutido em detalhe abaixo:
Motoristas
- AUMENTANDO A CONSCIENTIZAÇÃO SOBRE AS APLICAÇÕES NUTRACÊUTICAS
Nutracêutico é derivado de nutrição e farmacêutica. Os excipientes nutracêuticos, também conhecidos como ‘alimentos funcionais’, são componentes inativos preparados com Ingredientes Farmacêuticos Ativos (API) para aumentar o volume de soluções com ingredientes ativos poderosos. Estes excipientes nutracêuticos são utilizados em suplementos padronizados e de qualidade farmacêutica. O aumento vertiginoso dos custos médicos afetou significativamente o mercado dos excipientes nutracêuticos. Os excipientes são substâncias inertes, que não sejam medicamentos ativos, introduzidas no processo de fabrico ou incluídas na forma farmacêutica dos produtos nutracêuticos. Os excipientes são amplamente utilizados em formulações de medicamentos para adicionar volume às formulações sólidas, proporcionar estabilidade a longo prazo e facilitar a absorção do medicamento. Além disso, também melhora a segurança geral e as propriedades funcionais do produto durante a utilização ou armazenamento. A aplicação ampla e diversificada de excipientes tornou-os um nome familiar muito comum.
Assim, as amplas aplicações dos nutracêuticos no tratamento de doenças crónicas estão a aumentar a procura de excipientes no mercado norte-americano de excipientes nutracêuticos.
- AVANÇOS TECNOLÓGICOS EM EXCIPIENTES MULTIFUNCIONAIS
Os excipientes multifuncionais são uma classe de excipientes que inclui excipientes pré-processados e coprocessados que fornecem funcionalidades adicionais à formulação. A funcionalidade melhorada inclui fluidez, compressibilidade, distribuição do tamanho das partículas, forma e porosidade, entre outros.
O recente interesse em processos de fabrico exigentes e o foco em sistemas de entrega alternativos levaram ao aumento da procura por uma variedade de excipientes especiais conhecidos coletivamente como excipientes multifuncionais. Os sistemas de distribuição de medicamentos habilitados pela nanotecnologia são utilizados para fazer face à questão da toxicidade dos medicamentos. Existem duas abordagens principais para a utilização da nanotecnologia como sistema de distribuição de fármacos, como a redução do tamanho dos cristais dos fármacos nutracêuticos para garantir uma maior solubilidade e biodisponibilidade e a utilização de alguma forma de nanotransportador para a distribuição eficaz dos ingredientes ativos.
Restrição
- Aumento do rigor regulamentar em relação à aprovação de medicamentos e excipientes
As regras de aprovação de medicamentos genéricos são praticamente as mesmas em todo o mundo, com poucas diferenças nos países em desenvolvimento. Os governos devem garantir a qualidade consistente de todos os medicamentos genéricos. Uma das principais razões para a falta de confiança dos médicos (e mesmo dos doentes) nos medicamentos genéricos tem sido a falta de requisitos regulamentares rigorosos relativamente ao número de medicamentos genéricos e ao número de impurezas permitidas.
Assim, espera-se que um aumento do rigor regulamentar em relação à aprovação de excipientes e medicamentos restrinja o mercado norte-americano de excipientes nutracêuticos.
Oportunidade
-
Crescentes exigências por vias alternativas de entrega e formas farmacêuticas
Os nutracêuticos são derivados das palavras nutricional e farmacêutico. Os excipientes nutracêuticos são componentes inativos preparados com Ingredientes Farmacêuticos Ativos (API) para aumentar o volume de soluções que contenham ingredientes ativos potentes. Estes excipientes nutracêuticos são encontrados em suplementos padronizados e de qualidade farmacêutica.
O desenvolvimento de novos tratamentos ou suplementos preventivos, como nutracêuticos para doenças crónicas, o aumento do acesso a medicamentos através da produção de medicamentos genéricos e o aumento dos gastos em investigação e desenvolvimento são os principais factores para os quais as vias alternativas são um impulso.
Espera-se que o avanço no novo sistema de administração de fármacos (NDDS) e na formulação de dosagem alternativa e na via de administração aumente a procura pelo novo excipiente e atue como uma oportunidade para o crescimento do mercado.
Desafio
- Efeitos secundários associados com excipientes nutracêuticos:
A maioria dos nutracêuticos contém excipientes. São adicionados para diversos propósitos. Podem melhorar o desempenho do produto, incluindo a habilitação de formulações, a aceitação e adesão do doente, ou o fornecimento de um medicamento mais eficaz e seguro, como formulações de libertação modificada ou xaropes com sabor mascarado para crianças.
Os Excipientes Nutracêuticos nem sempre são as substâncias inertes que presumimos. São intolerantes a um indivíduo ou, se não forem devidamente rastreados, podem provocar alterações químicas no medicamento, provocando o efeito secundário. Isto pode afectar a procura do excipiente e deverá funcionar como um desafio para o mercado.
Impacto pós-COVID-19 no mercado norte-americano de excipientes nutracêuticos
A indústria nutracêutica foi severamente afetada pela pandemia COVID-19. Os bloqueios impostos devido à epidemia interromperam o fornecimento de matérias-primas de centros de produção como a Índia e a China. Isto retardou o desenvolvimento e a produção de medicamentos, afetando gravemente as empresas que dependiam fortemente da externalização. Inicialmente, todo o ecossistema nutracêutico foi perturbado. Além disso, as agências reguladoras tiveram de elaborar e redigir novas leis para garantir a máxima segurança do doente após a utilização de medicamentos. Após o fim das paragens, a indústria nutracêutica ganhou força, sobretudo devido à procura de medicamentos como a hidroxicloroquina e o Remdesivir, que apresentaram resultados positivos contra a COVID-19. A crescente procura por estes medicamentos impulsionou o volume de negócios de algumas empresas.
Desenvolvimentos recentes
- Em fevereiro de 2022, o Kerry Group Plc., empresa líder mundial em sabor e nutrição, anunciou que tinha realizado duas aquisições significativas de biotecnologia que expandiram a sua experiência, portfólio de tecnologia e capacidades de fabrico. A empresa anunciou que adquiriu a empresa líder em inovação em biotecnologia, c-LEcta, e o fabricante mexicano de enzimas, Enmex. A c-LEcta é uma empresa líder em inovação em biotecnologia, especializada em fermentação de precisão, bioprocessamento otimizado e biotransformação. Além disso, a Enmex é um fabricante de enzimas bem estabelecido, com sede no México, fornecendo diversas soluções de bioprocessos para os mercados de alimentos, bebidas e nutrição animal. Isto ajudou a empresa a aumentar a sua receita
- Em setembro de 2022, a DFE Pharma, líder na América do Norte em soluções de excipientes farmacêuticos e nutracêuticos, inaugurou o seu novo “Closer to the Formulator” (C2F), um Centro de Excelência, em Hyderabad, na Índia. A C2F ajudou as empresas farmacêuticas a reduzir o tempo desde o conceito até ao produto comercial acabado através da sua experiência em todas as fases do desenvolvimento farmacêutico. Isto ajudou a empresa a mostrar o seu progresso
Âmbito do mercado de excipientes nutracêuticos da América do Norte
O mercado norte-americano de excipientes nutracêuticos está segmentado em tipo, produtos finais, forma, fonte de excipientes e canal de distribuição. O crescimento entre segmentos ajuda-o a analisar os nichos de crescimento e as estratégias para abordar o mercado e determinar as suas principais áreas de aplicação e a diferença nos seus mercados-alvo.
MERCADO DE EXCIPIENTES NUTRACÊUTICOS DA AMÉRICA DO NORTE, POR TIPO
- PASTAS
- PREENCHIMENTOS E DILUENTES
- DESINTEGRANTES
- MATERIAL DE REVESTIMENTO
- AGENTES CORANTES
- AROMATIZANTES
- ADOÇANTES
- LUBRIFICANTES
- TAMPÕES
- CONSERVANTES
- ESPESSANTES/AGENTES GELIFICANTES
- AGENTES MOLHADORES
- AGENTES DE PLANEAMENTO
- SOLVENTES
- TRANSPORTADORAS
- ANTIESPUMANTES
- OUTROS
Com base no tipo, o mercado norte-americano de excipientes nutracêuticos está segmentado em Agentes Aromatizantes, Agentes Colorantes, Adoçantes, Agente de Revestimento, Tampões, Solventes, Transportadores, Antiespumantes, Agentes Deslizantes, Agentes Humectantes, Espessantes/Agentes Gelificantes, Conservantes, Ligantes, Desintegrantes , Lubrificantes, Enchimentos e Diluentes e outros.
MERCADO DE EXCIPIENTES NUTRACÊUTICOS DA AMÉRICA DO NORTE, POR PRODUTOS FINAIS
- PASTAS
- PREENCHIMENTOS E DILUENTES
- DESINTEGRA
- MATERIAL DE REVESTIMENTO
- AGENTES CORANTES
- AROMATIZANTES
- ADOÇANTES
- LUBRIFICANTES
- TAMPÕES
- CONSERVANTES
- ESPESSANTES/AGENTES GELIFICANTES
- AGENTES MOLHADORES
- AGENTES DE PLANEAMENTO
- SOLVENTES
- TRANSPORTADORAS
- ANTIESPUMANTES
- OUTROS
Com base nos produtos finais, o mercado norte-americano de excipientes nutracêuticos está segmentado em prebióticos por excipientes, probióticos por excipientes, suplementos de proteínas e aminoácidos por excipientes, suplementos minerais por excipientes, suplementos vitamínicos, suplementos de ómega-3 por excipientes e outros suplementos.
MERCADO DE EXCIPIENTES NUTRACÊUTICOS DA AMÉRICA DO NORTE, POR FORMULÁRIO
- SECO
- LÍQUIDO
Com base na forma, o mercado norte-americano de excipientes nutracêuticos está segmentado em seco e líquido.
MERCADO DE EXCIPIENTES NUTRACÊUTICOS DA AMÉRICA DO NORTE, POR FONTE DE EXCIPIENTE
- NATURAL
- SINTÉTICO
Com base na fonte de excipientes, o mercado norte-americano de excipientes nutracêuticos está segmentado em naturais e sintéticos.
MERCADO DE EXCIPIENTES FARMACÊUTICOS DA AMÉRICA DO NORTE, POR CANAL DE DISTRIBUIÇÃO
- CONCURSO DIRETO
- VENDAS NO VAREJO
- OUTROS
Com base no canal de distribuição, o mercado norte-americano de excipientes nutracêuticos está segmentado em concurso direto, vendas a retalho e outros.
Análise/perspetivas regionais do mercado norte-americano de excipientes nutracêuticos
O mercado norte-americano de excipientes nutracêuticos é analisado e são fornecidas informações sobre o tamanho do mercado, tipo, produtos finais, forma, fonte de excipiente e canal de distribuição.
Os países abordados neste relatório de mercado são os EUA, Canadá, México.
Os EUA estão a dominar devido à presença de intervenientes-chave no maior mercado consumidor com um PIB elevado. Espera-se que cresça devido ao aumento do avanço tecnológico nas TI de saúde.
A secção de países do relatório também fornece fatores individuais que impactam o mercado e alterações na regulamentação do mercado interno que impactam as tendências atuais e futuras do mercado. Dados como novas vendas, vendas de reposição, demografia do país, atos regulamentares e tarifas de importação e exportação são alguns dos principais indicadores utilizados para prever o cenário de mercado para países individuais. Além disso, são considerados a presença e disponibilidade de marcas da América do Norte e os desafios enfrentados devido à concorrência grande ou escassa de marcas locais e nacionais, e o impacto dos canais de vendas, ao mesmo tempo que se fornece uma análise de previsão dos dados do país.
Análise do cenário competitivo e da quota de mercado dos excipientes nutracêuticos na América do Norte
O panorama competitivo do mercado norte-americano de excipientes nutracêuticos fornece detalhes do concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em I&D, novas iniciativas de mercado, localizações e instalações de produção, pontos fortes e fracos da empresa, lançamento de produtos, pipelines de testes de produtos, aprovações de produtos, patentes, largura e respiração do produto, domínio da aplicação, curva da linha de vida da tecnologia. Os dados fornecidos acima estão apenas relacionados com o foco da empresa no mercado norte-americano de excipientes nutracêuticos.
Alguns dos principais players que operam no mercado norte-americano de excipientes nutracêuticos são a BASF SE., DuPont, Ingredion Incorporated, WR Grace and Co, Kerry Group, Sensient Technologies, Roquette Pharma Solutions, Cargill, Ashland. SEPPIC, Gatefosse, Pioma Chemicals, Omya., Gangwal Chemicals Private Limited, Grain Processing Corporation, IMCD Group., JRS Pharma LP, Azelis, Jigs Chemical, Sigaichi Industries, Beneo e Abitec, entre outros.
SKU-
Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo
- Painel interativo de análise de dados
- Painel de análise da empresa para oportunidades de elevado potencial de crescimento
- Acesso de analista de pesquisa para personalização e customização. consultas
- Análise da concorrência com painel interativo
- Últimas notícias, atualizações e atualizações Análise de tendências
- Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Índice
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 ORIGIN LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHT
4.1 FUTURE PERSPECTIVE ON THE NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET
4.2 SUPPLY CHAIN
4.2.1 RAW MATERIAL PROCUREMENT
4.2.2 MANUFACTURING
4.2.3 MARKETING & DISTRIBUTION
4.2.4 END USERS
4.2.5 LOGISTIC COST SCENARIO
4.2.6 IMPORTANCE OF LOGISTIC SERVICE PROVIDER
4.3 VALUE CHAIN ANALYSIS
5 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET, REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING AWARENESS REGARDING NUTRACEUTICAL APPLICATIONS
6.1.2 TECHNOLOGICAL ADVANCEMENTS IN MULTIFUNCTIONAL EXCIPIENTS
6.1.3 RISE IN NUTRACEUTICAL DRUG PRODUCTION AND USES
6.1.4 INCREASING PREVALENCE OF LIFESTYLE DISEASES AND CHRONIC HEART DISEASES
6.2 RESTRAINTS
6.2.1 INCREASING REGULATORY STRINGENCY REGARDING THE APPROVAL OF DRUGS AND EXCIPIENTS
6.2.2 HIGH PRODUCTION COST
6.3 OPPORTUNITIES
6.3.1 INCREASING DEMANDS FOR ALTERNATIVE ROUTES OF DELIVERY AND DOSAGE FORMS
6.3.2 RISE IN DEMAND FOR MULTIFUNCTIONAL EXCIPIENTS
6.3.3 RISING DISPOSABLE INCOME
6.4 CHALLENGES
6.4.1 ASSOCIATED SIDE EFFECTS WITH NUTRACEUTICAL EXCIPIENTS:
6.4.2 SAFETY CONSIDERATION OF NUTRACEUTICAL EXCIPIENTS IN STORAGE AND TRANSPORTATION
7 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE
7.1 OVERVIEW
7.2 BINDERS
7.2.1 SYNTHETIC/ SEMISYNTHETIC
7.2.2 NATURAL
7.2.3 HMPC
7.2.4 MCC
7.2.5 HPC
7.3 FILLER AND DILUENTS
7.4 DISINTEGRANTS
7.4.1 BY SYNTHESIS
7.4.1.1 SYNTHETIC/ SEMISYNTHETIC
7.4.1.2 NATURAL
7.4.2 BY TYPE
7.4.2.1 CROSSPOVIDONE
7.4.2.2 CROSCAMELLOSE
7.5 COATING MATERIAL
7.5.1 BY FUNCTIONALITY
7.5.1.1 FUNCTIONAL COATING AGENTS
7.5.1.2 NON-FUNCTIONAL COATING AGENTS
7.5.2 BY COATING TYPE
7.5.2.1 ENTERIC COATING
7.5.2.2 FILM COATING
7.5.2.3 GELATIN COATING
7.5.2.4 SUGAR COATING
7.5.2.5 OTHERS
7.6 COLORING AGENTS
7.6.1 SYNTHETIC COLORING AGENT
7.6.1.1 GREEN S
7.6.1.2 PATENT BLUE V
7.6.1.3 QUINOLINE YELLOW
7.6.1.4 CARMOISINE
7.6.1.5 PONCEAU 4R
7.6.1.6 OTHERS
7.6.2 NATURAL COLORING AGENT
7.6.2.1 PLANT DERIVED
7.6.2.1.1 INDIGO
7.6.2.1.2 BETA-CAROTENE
7.6.2.1.3 PAPRIKA
7.6.2.1.4 TURMERIC
7.6.2.1.5 SAFFRON
7.6.2.1.6 OTHERS
7.6.2.2 ANIMAL DERIVED
7.6.2.2.1 COCHNINEAL EXTRACT
7.6.2.2.2 OTHERS
7.6.2.3 MINERAL DERIVED
7.6.2.3.1 RED FERRIC OXIDE
7.6.2.3.2 TITANIUM OXIDE
7.6.2.3.3 LEAD OXIDE
7.6.2.3.4 COPPER SULPHATE
7.6.2.3.5 CARBON BLACK
7.6.2.3.6 OTHERS
7.7 FLAVORING AGENTS
7.7.1 BY FORM
7.7.1.1 DRY
7.7.1.2 LIQUID
7.7.2 BY TYPE
7.7.2.1 ARTIFICIAL OR SYNTHETIC FLAVORING AGENT
7.7.2.2 NATURAL FLAVORING AGENT
7.8 SWEETENERS
7.8.1 BY SOURCE
7.8.1.1 ARTIFICIAL SWEETENERS
7.8.1.2 NATURAL SWEETENERS
7.8.2 BY CALORIE
7.8.2.1 NUTRITIVE OR CALORIE SWEETENING AGENTS
7.8.2.2 NON-NUTRITIVE OR LOW CALORIE SWEETENING AGENTS
7.9 LUBRICANTS
7.9.1 BY FORM
7.9.1.1 DRY
7.9.1.2 LIQUID
7.9.2 BY SOLUBILITY
7.9.2.1 WATER SOLUBLE
7.9.2.2 WATER INSOLUBLE
7.1 BUFFERS
7.11 PRESERVATIVES
7.11.1 CHEMICAL PRESERVATIVES
7.11.1.1 BENZOATES
7.11.1.2 NITRILES
7.11.1.3 SULPHITES
7.11.1.4 SORBATES
7.11.1.5 OTHERS
7.11.2 ARTIFICIAL PRESERVATIVES
7.11.2.1 ANTIMICROBIAL AGENTS
7.11.2.2 ANTIOXIDANTS
7.11.2.3 CHELATING AGENTS
7.11.2.4 OTHERS
7.11.3 NATURAL PRESERVATIVES
7.12 THICKENERS/ GELLING AGENTS
7.12.1 SODIUM ALGINATE
7.12.2 PROPYLENE GLYCOL
7.12.3 XANTHAN GUM
7.12.4 GUAR GUM
7.12.5 LOCUST BEAN GUM
7.12.6 OTHERS
7.13 WETTING AGENTS
7.13.1 ANIONIC
7.13.2 CATIONIC
7.13.3 AMPHOTERIC
7.13.4 NONIONIC
7.14 GLIDING AGENTS
7.14.1 COLLOIDAL SILICON DIOXIDE
7.14.2 TALC
7.14.3 TRIBASIC CALCIUM PHOSPHATE
7.14.4 CALCIUM SILICATE
7.14.5 MAGNESIUM OXIDE
7.14.6 SODIUM STEARATE
7.14.7 MAGNESIUM SILICATE
7.14.8 SILICA
7.14.9 MAGNESIUM TRISILICATE
7.14.10 HYDROPHOBIC COLLOIDAL SILICA
7.14.11 OTHERS
7.15 SOLVENTS
7.15.1 POLAR
7.15.2 NON POLAR
7.16 CARRIERS
7.17 ANTIFOAMS
7.18 OTHERS
8 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCTS
8.1 OVERVIEW
8.2 PROBIOTICS
8.2.1 BINDERS
8.2.2 FILLERS AND DILUENTS
8.2.3 DISINTEGRANTS
8.2.4 COATING MATERIAL
8.2.5 COLORING AGENTS
8.2.6 FLAVORING AGENTS
8.2.7 SWEETENERS
8.2.8 LUBRICANTS
8.2.9 BUFFERS
8.2.10 PRESERVATIVES
8.2.11 THICKENERS/GELLING AGENTS
8.2.12 WETTING AGENT
8.2.13 GLIDING AGENT
8.2.14 SOLVENTS
8.2.15 CARRIERS
8.2.16 ANTIFOAMS
8.2.17 OTHERS
8.3 PREBIOTICS
8.3.1 BINDERS
8.3.2 FILLERS AND DILUENTS
8.3.3 DISINTEGRANTS
8.3.4 COATING MATERIAL
8.3.5 COLORING AGENTS
8.3.6 FLAVORING AGENTS
8.3.7 SWEETENERS
8.3.8 LUBRICANTS
8.3.9 BUFFERS
8.3.10 PRESERVATIVES
8.3.11 THICKENERS/GELLING AGENTS
8.3.12 WETTING AGENT
8.3.13 GLIDING AGENT
8.3.14 SOLVENTS
8.3.15 CARRIERS
8.3.16 ANTIFOAMS
8.3.17 OTHERS
8.4 PROTEIN AND AMINO ACID SUPPLEMENTS
8.4.1 BINDERS
8.4.2 FILLERS AND DILUENTS
8.4.3 DISINTEGRANTS
8.4.4 COATING MATERIAL
8.4.5 COLORING AGENTS
8.4.6 FLAVORING AGENTS
8.4.7 SWEETENERS
8.4.8 LUBRICANTS
8.4.9 BUFFERS
8.4.10 PRESERVATIVES
8.4.11 THICKENERS/GELLING AGENTS
8.4.12 WETTING AGENT
8.4.13 GLIDING AGENT
8.4.14 SOLVENTS
8.4.15 CARRIERS
8.4.16 ANTIFOAMS
8.4.17 OTHERS
8.5 VITAMIN SUPPLEMENTS
8.5.1 BY TYPE
8.5.1.1 VITAMIN B
8.5.1.1.1 VITAMIN B12
8.5.1.1.2 VITAMIN B6
8.5.1.1.3 VITAMIN B3
8.5.1.1.4 VITAMIN B1
8.5.1.1.5 VITAMIN B2
8.5.1.1.6 OTHERS
8.5.1.2 VITAMIN C
8.5.1.3 VITAMIN D
8.5.1.4 VITAMIN E
8.5.1.5 VITAMIN A
8.5.1.6 OTHERS
8.5.2 BY EXCIPIENTS
8.5.2.1 BINDERS
8.5.2.2 FILLERS AND DILUENTS
8.5.2.3 DISINTEGRANTS
8.5.2.4 COATING MATERIAL
8.5.2.5 COLORING AGENTS
8.5.2.6 FLAVORING AGENTS
8.5.2.7 SWEETENERS
8.5.2.8 LUBRICANTS
8.5.2.9 BUFFERS
8.5.2.10 PRESERVATIVES
8.5.2.11 THICKENERS/GELLING AGENTS
8.5.2.12 WETTING AGENT
8.5.2.13 GLIDING AGENT
8.5.2.14 SOLVENTS
8.5.2.15 CARRIERS
8.5.2.16 ANTIFOAMS
8.5.2.17 OTHERS
8.6 MINERAL SUPPLEMENTS
8.6.1 BINDERS
8.6.2 FILLERS AND DILUENTS
8.6.3 DISINTEGRANTS
8.6.4 COATING MATERIAL
8.6.5 COLORING AGENTS
8.6.6 FLAVORING AGENTS
8.6.7 SWEETENERS
8.6.8 LUBRICANTS
8.6.9 BUFFERS
8.6.10 PRESERVATIVES
8.6.11 THICKENERS/GELLING AGENTS
8.6.12 WETTING AGENT
8.6.13 GLIDING AGENT
8.6.14 SOLVENTS
8.6.15 CARRIERS
8.6.16 ANTIFOAMS
8.6.17 OTHERS
8.7 OMEGA-3 SUPPLEMENTS
8.7.1 BINDERS
8.7.2 FILLERS AND DILUENTS
8.7.3 DISINTEGRANTS
8.7.4 COATING MATERIAL
8.7.5 COLORING AGENTS
8.7.6 FLAVORING AGENTS
8.7.7 SWEETENERS
8.7.8 LUBRICANTS
8.7.9 BUFFERS
8.7.10 PRESERVATIVES
8.7.11 THICKENERS/GELLING AGENTS
8.7.12 WETTING AGENT
8.7.13 GLIDING AGENT
8.7.14 SOLVENTS
8.7.15 CARRIERS
8.7.16 ANTIFOAMS
8.7.17 OTHERS
8.8 OTHER SUPPLEMENTS
8.8.1 BINDERS
8.8.2 FILLERS AND DILUENTS
8.8.3 DISINTEGRANTS
8.8.4 COATING MATERIAL
8.8.5 COLORING AGENTS
8.8.6 FLAVORING AGENTS
8.8.7 SWEETENERS
8.8.8 LUBRICANTS
8.8.9 BUFFERS
8.8.10 PRESERVATIVES
8.8.11 THICKENERS/GELLING AGENTS
8.8.12 WETTING AGENT
8.8.13 GLIDING AGENT
8.8.14 SOLVENTS
8.8.15 CARRIERS
8.8.16 ANTIFOAMS
8.8.17 OTHERS
9 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM
9.1 OVERVIEW
9.2 DRY
9.3 LIQUID
10 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENT SOURCE
10.1 OVERVIEW
10.2 SYNTHETIC
10.3 NATURAL
10.3.1 PLANT
10.3.2 ANIMAL
10.3.3 MINERAL
11 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDER
11.3 RETAIL SALES
11.3.1 MASS MERCHANDISE
11.3.2 ONLINE STORES
11.3.3 OTHERS
11.4 OTHERS
12 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION
12.1 NORTH AMERICA
12.1.1 U.S.
12.1.2 CANADA
12.1.3 MEXICO
13 NORTH AMERICA NUTRACEUTICAL EXCIPIENT MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
14 SWOT ANALYSIS
15 COMPANY PROFILE
15.1 INGREDION. (2022)
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENTS
15.2 BASF SE (2022)
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENT
15.3 AZELIS (2022)
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 COMPANY SHARE ANALYSIS
15.3.4 PRODUCT PORTFOLIO
15.3.5 RECENT DEVELOPMENT
15.4 CARGILL, INCORPORATED.
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPMENT
15.5 JRS PHARMA
15.5.1 COMPANY SNAPSHOT
15.5.2 COMPANY SHARE ANALYSIS
15.5.3 PRODUCT PORTFOLIO
15.5.4 RECENT DEVELOPMENT
15.6 ABITEC
15.6.1 COMPANY SNAPSHOT
15.6.2 PRODUCT PORTFOLIO
15.6.3 RECENT DEVELOPMENT
15.7 ASHLAND (2022)
15.7.1 COMPANY SNAPSHOT
15.7.2 REVENUE ANALYSIS
15.7.3 PRODUCT PORTFOLIO
15.7.4 RECENT DEVELOPMENT
15.8 BENEO (A SUBSIDIARY OF SUDZUCKER)
15.8.1 COMPANY SNAPSHOT
15.8.2 REVENUE ANALYSIS
15.8.3 PRODUCT PORTFOLIO
15.8.4 RECENT DEVELOPMENT
15.9 DUPONT (A SUBSIDIARY OF DUPONT DE NEMOURS, INC.) (2022)
15.9.1 COMPANY SNAPSHOT
15.9.2 REVENUE ANALYSIS
15.9.3 PRODUCT PORTFOLIO
15.9.4 RECENT DEVELOPMENT
15.1 GANGWAL CHEMICALS PVT. LTD.
15.10.1 COMPANY SNAPSHOT
15.10.2 PRODUCT PORTFOLIO
15.10.3 RECENT DEVELOPMENT
15.11 GATTEFOSSE
15.11.1 COMPANY SNAPSHOT
15.11.2 PRODUCT PORTFOLIO
15.11.3 RECENT DEVELOPMENT
15.12 GRAIN PROCESSING CORPORATION (2022)
15.12.1 COMPANY SNAPSHOT
15.12.2 REVENUE ANALYSIS
15.12.3 PRODUCT PORTFOLIO
15.12.4 RECENT DEVELOPMENT
15.13 IMCD (2022)
15.13.1 COMPANY SNAPSHOT
15.13.2 REVENUE ANALYSIS
15.13.3 PRODUCT PORTFOLIO
15.13.4 RECENT DEVELOPMENT
15.14 JIGS CHEMICAL
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT DEVELOPMENT
15.15 KERRY GROUP PLC.
15.15.1 COMPANY SNAPSHOT
15.15.2 REVENUE ANALYSIS
15.15.3 PRODUCT PORTFOLIO
15.15.4 RECENT DEVELOPMENT
15.16 OMYA
15.16.1 COMPANY SNAPSHOT
15.16.2 PRODUCT PORTFOLIO
15.16.3 RECENT DEVELOPMENT
15.17 PIOMA CHEMICALS
15.17.1 COMPANY SNAPSHOT
15.17.2 PRODUCT PORTFOLIO
15.17.3 RECENT DEVELOPMENT
15.18 ROQUETTE FRÈRES
15.18.1 COMPANY SNAPSHOT
15.18.2 PRODUCT PORTFOLIO
15.18.3 RECENT DEVELOPMENTS
15.19 SENSIENT TECHNOLOGIES CORPORATION (2022)
15.19.1 COMPANY SNAPSHOT
15.19.2 REVENUE ANALYSIS
15.19.3 PRODUCT PORTFOLIO
15.19.4 RECENT DEVELOPMENT
15.2 SEPPIC
15.20.1 COMPANY SNAPSHOT
15.20.2 PRODUCT PORTFOLIO
15.20.3 RECENT DEVELOPMENT
15.21 SIGACHI INDUSTRIES (2022)
15.21.1 COMPANY SNAPSHOT
15.21.2 REVENUE ANALYSIS
15.21.3 PRODUCT PORTFOLIO
15.21.4 RECENT DEVELOPMENT
15.22 W.R. GRACE & CO.-CONN
15.22.1 COMPANY SNAPSHOT
15.22.2 PRODUCT PORTFOLIO
15.22.3 RECENT DEVELOPMENT
16 QUESTIONNAIRE
17 RELATED REPORTS
Lista de Tabela
TABLE 1 THIS GUIDELINE REQUIRES MARKETING AUTHORIZATION HOLDERS TO DISPLAY EXCIPIENTS IN THE FOLLOWING WAYS:
TABLE 2 APPLICATIONS OF NUTRACEUTICALS
TABLE 3 NUTRACEUTICAL DRUG PRODUCTS
TABLE 4 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 5 NORTH AMERICA BINDERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 6 NORTH AMERICA BINDERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 7 NORTH AMERICA FILLER AND DILUENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 8 NORTH AMERICA DISINTEGRANTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 9 NORTH AMERICA DISINTEGRANTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY SYNTHESIS, 2021-2030 (USD MILLION)
TABLE 10 NORTH AMERICA DISINTEGRANTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 11 NORTH AMERICA COATING MATERIAL IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 12 NORTH AMERICA COATING MATERIAL IN NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021-2030 (USD MILLION)
TABLE 13 NORTH AMERICA COATING MATERIAL IN NUTRACEUTICAL EXCIPIENTS MARKET, BY COATING TYPE, 2021-2030 (USD MILLION)
TABLE 14 NORTH AMERICA COLORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 15 NORTH AMERICA COLORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 16 NORTH AMERICA SYNTHETIC COLORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 17 NORTH AMERICA NATURAL COLORING AGENT IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 18 NORTH AMERICA PLANT DERIVED IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 19 NORTH AMERICA ANIMAL DERIVED IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 20 NORTH AMERICA MINERAL DERIVED IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 21 NORTH AMERICA FLAVORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 22 NORTH AMERICA FLAVORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM, 2021-2030 (USD MILLION)
TABLE 23 NORTH AMERICA FLAVORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 24 NORTH AMERICA SWEETENERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 25 NORTH AMERICA SWEETENERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 26 NORTH AMERICA SWEETENERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY CALORIE, 2021-2030 (USD MILLION)
TABLE 27 NORTH AMERICA LUBRICANTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 28 NORTH AMERICA LUBRICANTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM, 2021-2030 (USD MILLION)
TABLE 29 NORTH AMERICA LUBRICANTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY SOLUBILITY, 2021-2030 (USD MILLION)
TABLE 30 NORTH AMERICA BUFFERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 31 NORTH AMERICA PRESERVATIVES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 32 NORTH AMERICA PRESERVATIVES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 33 NORTH AMERICA CHEMICAL PRESERVATIVES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 34 NORTH AMERICA ARTIFICIAL PRESERVATIVES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 35 NORTH AMERICA THICKENERS/ GELLING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 36 NORTH AMERICA THICKENERS/ GELLING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 37 NORTH AMERICA WETTING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 38 NORTH AMERICA WETTING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 39 NORTH AMERICA GLIDING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 40 NORTH AMERICA GLIDING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 41 NORTH AMERICA SOLVENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 42 NORTH AMERICA SOLVENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 43 NORTH AMERICA CARRIERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 44 NORTH AMERICA ANTIFOAMS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 45 NORTH AMERICA OTHERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 46 NORTH AMERICA NUTRACEUTICAL EXCIPIENT MARKET, BY END PRODUCTS, 2021-2030 (USD MILLION)
TABLE 47 NORTH AMERICA PROBIOTICS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 48 NORTH AMERICA PROBIOTICS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 49 NORTH AMERICA PREBIOTICS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 50 NORTH AMERICA PREBIOTICS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 51 NORTH AMERICA PROTEIN AND AMINO ACID SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 52 NORTH AMERICA PROTEIN AND AMINO ACID SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 53 NORTH AMERICA VITAMIN SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 54 NORTH AMERICA VITAMIN SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 55 NORTH AMERICA VITAMIN B IN NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 56 NORTH AMERICA VITAMIN SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 57 NORTH AMERICA MINERAL SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 58 NORTH AMERICA MINERAL SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 59 NORTH AMERICA OMEGA-3 SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 60 NORTH AMERICA OMEGA-3 SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 61 NORTH AMERICA OTHER SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 62 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM, 2021-2030 (USD MILLION)
TABLE 63 NORTH AMERICA DRY IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 64 NORTH AMERICA LIQUID IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 65 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENT SOURCE, 2021-2030 (USD MILLION)
TABLE 66 NORTH AMERICA SYNTHETIC IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 67 NORTH AMERICA NATURAL IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 68 NORTH AMERICA NATURAL IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENT SOURCE, 2021-2030 (USD MILLION)
TABLE 69 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 70 NORTH AMERICA DIRECT TENDER IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 71 NORTH AMERICA RETAIL SALES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 72 NORTH AMERICA RETAIL SALES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 73 NORTH AMERICA OTHERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 74 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 75 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 76 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 77 NORTH AMERICA BINDERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 78 NORTH AMERICA DISINTEGRANTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY SYNTHESIS, 2021-2030 (USD MILLION)
TABLE 79 NORTH AMERICA DISINTEGRANTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 80 NORTH AMERICA COATING MATERIAL IN NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021-2030 (USD MILLION)
TABLE 81 NORTH AMERICA COATING MATERIAL IN NUTRACEUTICAL EXCIPIENTS MARKET, BY COATING TYPE, 2021-2030 (USD MILLION)
TABLE 82 NORTH AMERICA COLORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 83 NORTH AMERICA SYNTHETIC COLORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 84 NORTH AMERICA NATURAL COLORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 85 NORTH AMERICA PLANT DERIVED IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 86 NORTH AMERICA ANIMAL DERIVED IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 87 NORTH AMERICA MINERAL DERIVED IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 88 NORTH AMERICA FLAVORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM, 2021-2030 (USD MILLION)
TABLE 89 NORTH AMERICA FLAVORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 90 NORTH AMERICA SWEETENERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 91 NORTH AMERICA SWEETENERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY CALORIE, 2021-2030 (USD MILLION)
TABLE 92 NORTH AMERICA LUBRICANTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM, 2021-2030 (USD MILLION)
TABLE 93 NORTH AMERICA LUBRICANTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY SOLUBILITY, 2021-2030 (USD MILLION)
TABLE 94 NORTH AMERICA PRESERVATIVES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 95 NORTH AMERICA CHEMICAL PRESERVATIVES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 96 NORTH AMERICA ARTIFICIAL PRESERVATIVES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 97 NORTH AMERICA THICKENER AND GELLING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 98 NORTH AMERICA WETTING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 99 NORTH AMERICA GLIDING AGENTS IN NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 100 NORTH AMERICA SOLVENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 101 NORTH AMERICA NUTRACEUTICAL EXCIPIENT MARKET, BY END PRODUCTS, 2021-2030 (USD MILLION)
TABLE 102 NORTH AMERICA PROBIOTICS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 103 NORTH AMERICA PREBIOTICS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 104 NORTH AMERICA PROTEIN AND AMINO ACID SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 105 NORTH AMERICA VITAMIN SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 106 NORTH AMERICA VITAMIN B IN NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 107 NORTH AMERICA VITAMIN SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 108 NORTH AMERICA MINERAL SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 109 NORTH AMERICA OMEGA-3 SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 110 NORTH AMERICA OTHERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 111 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM, 2021-2030 (USD MILLION)
TABLE 112 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENT SOURCE, 2021-2030 (USD MILLION)
TABLE 113 NORTH AMERICA NATURAL IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENT SOURCE, 2021-2030 (USD MILLION)
TABLE 114 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 115 NORTH AMERICA RETAIL SALES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 116 U.S. NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 117 U.S. NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 118 U.S. NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCTS, 2021-2030, (ASP)
TABLE 119 U.S. BINDERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 120 U.S. DISINTEGRATES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY SYNTHESIS, 2021-2030 (USD MILLION)
TABLE 121 U.S. DISINTEGRATES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 122 U.S. COATING MATERIAL IN NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021-2030 (USD MILLION)
TABLE 123 U.S. COATING MATERIAL IN NUTRACEUTICAL EXCIPIENTS MARKET, BY COATING TYPE, 2021-2030 (USD MILLION)
TABLE 124 U.S. COLORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 125 U.S. SYNTHETIC COLORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 126 U.S. NATURAL COLORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 127 U.S. PLANT DERIVED IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 128 U.S. ANIMAL DERIVED IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 129 U.S. MINERAL DERIVED IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 130 U.S. FLAVORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM, 2021-2030 (USD MILLION)
TABLE 131 U.S. FLAVORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 132 U.S. SWEETENERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 133 U.S. SWEETENERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY CALORIE, 2021-2030 (USD MILLION)
TABLE 134 U.S. LUBRICANTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM, 2021-2030 (USD MILLION)
TABLE 135 U.S. LUBRICANTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY SOLUBILITY, 2021-2030 (USD MILLION)
TABLE 136 U.S. PRESERVATIVES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 137 U.S. CHEMICAL PRESERVATIVES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 138 U.S. ARTIFICIAL PRESERVATIVES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 139 U.S. THICKENER AND GELLING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 140 U.S. WETTING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 141 U.S. GLIDING AGENTS IN NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 142 U.S. SOLVENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 143 U.S. NUTRACEUTICAL EXCIPIENT MARKET, BY END PRODUCTS, 2021-2030 (USD MILLION)
TABLE 144 U.S. PROBIOTICS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 145 U.S. PREBIOTICS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 146 U.S. PROTEIN AND AMINO ACID SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 147 U.S. VITAMIN SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 148 U.S. VITAMIN B IN NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 149 U.S. VITAMIN SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 150 U.S. MINERAL SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 151 U.S. OMEGA-3 SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 152 U.S. OTHERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 153 U.S. NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM, 2021-2030 (USD MILLION)
TABLE 154 U.S. NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENT SOURCE, 2021-2030 (USD MILLION)
TABLE 155 U.S NATURAL IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENT SOURCE, 2021-2030 (USD MILLION)
TABLE 156 U.S. NUTRACEUTICAL EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 157 U.S. RETAIL SALES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 158 CANADA NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 159 CANADA NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 160 CANADA NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCTS, 2021-2030, (ASP)
TABLE 161 CANADA BINDERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 162 CANADA DISINTEGRANTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY SYNTHESIS, 2021-2030 (USD MILLION)
TABLE 163 CANADA DISINTEGRANTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 164 CANADA COATING MATERIAL IN NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021-2030 (USD MILLION)
TABLE 165 CANADA COATING MATERIAL IN NUTRACEUTICAL EXCIPIENTS MARKET, BY COATING TYPE, 2021-2030 (USD MILLION)
TABLE 166 CANADA COLORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 167 CANADA SYNTHETIC COLORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 168 CANADA NATURAL COLORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 169 CANADA PLANT DERIVED IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 170 CANADA ANIMAL DERIVED IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 171 CANADA MINERAL DERIVED IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 172 CANADA FLAVORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM, 2021-2030 (USD MILLION)
TABLE 173 CANADA FLAVORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 174 CANADA SWEETENERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 175 CANADA SWEETENERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY CALORIE, 2021-2030 (USD MILLION)
TABLE 176 CANADA LUBRICANTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM, 2021-2030 (USD MILLION)
TABLE 177 CANADA LUBRICANTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY SOLUBILITY, 2021-2030 (USD MILLION)
TABLE 178 CANADA PRESERVATIVES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 179 CANADA CHEMICAL PRESERVATIVES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 180 CANADA ARTIFICIAL PRESERVATIVES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 181 CANADA THICKENER AND GELLING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 182 CANADA WETTING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 183 CANADA GLIDING AGENTS IN NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 184 CANADA SOLVENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 185 CANADA NUTRACEUTICAL EXCIPIENT MARKET, BY END PRODUCTS, 2021-2030 (USD MILLION)
TABLE 186 CANADA PROBIOTICS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 187 CANADA PREBIOTICS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 188 CANADA PROTEIN AND AMINO ACID SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 189 CANADA VITAMIN SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 190 CANADA VITAMIN B IN NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 191 CANADA VITAMIN SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 192 CANADA MINERAL SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 193 CANADA OMEGA-3 SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 194 CANADA OTHERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 195 CANADA NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM, 2021-2030 (USD MILLION)
TABLE 196 CANADA NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENT SOURCE, 2021-2030 (USD MILLION)
TABLE 197 CANADA NATURAL IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENT SOURCE, 2021-2030 (USD MILLION)
TABLE 198 CANADA NUTRACEUTICAL EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 199 CANADA RETAIL SALES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 200 MEXICO NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 201 MEXICO NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 202 MEXICO NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCTS, 2021-2030, (ASP)
TABLE 203 MEXICO BINDERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 204 MEXICO DISINTEGRANTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY SYNTHESIS, 2021-2030 (USD MILLION)
TABLE 205 MEXICO DISINTEGRANTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 206 MEXICO COATING MATERIAL IN NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021-2030 (USD MILLION)
TABLE 207 MEXICO COATING MATERIAL IN NUTRACEUTICAL EXCIPIENTS MARKET, BY COATING TYPE, 2021-2030 (USD MILLION)
TABLE 208 MEXICO COLORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 209 MEXICO SYNTHETIC COLORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 210 MEXICO NATURAL COLORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 211 MEXICO PLANT DERIVED IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 212 MEXICO ANIMAL DERIVED IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 213 MEXICO MINERAL DERIVED IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 214 MEXICO FLAVORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM, 2021-2030 (USD MILLION)
TABLE 215 MEXICO FLAVORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 216 MEXICO SWEETENERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 217 MEXICO SWEETENERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY CALORIE, 2021-2030 (USD MILLION)
TABLE 218 MEXICO LUBRICANTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM, 2021-2030 (USD MILLION)
TABLE 219 MEXICO LUBRICANTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY SOLUBILITY, 2021-2030 (USD MILLION)
TABLE 220 MEXICO PRESERVATIVES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 221 MEXICO CHEMICAL PRESERVATIVES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 222 MEXICO ARTIFICIAL PRESERVATIVES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 223 MEXICO THICKENER AND GELLING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 224 MEXICO WETTING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 225 MEXICO GLIDING AGENTS IN NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 226 MEXICO SOLVENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 227 MEXICO NUTRACEUTICAL EXCIPIENT MARKET, BY END PRODUCTS, 2021-2030 (USD MILLION)
TABLE 228 MEXICO PROBIOTICS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 229 MEXICO PREBIOTICS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 230 MEXICO PROTEIN AND AMINO ACID SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 231 MEXICO VITAMIN SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 232 MEXICO VITAMIN B IN NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 233 MEXICO VITAMIN SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 234 MEXICO MINERAL SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 235 MEXICO OMEGA-3 SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 236 MEXICO OTHERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 237 MEXICO NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM, 2021-2030 (USD MILLION)
TABLE 238 MEXICO NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENT SOURCE, 2021-2030 (USD MILLION)
TABLE 239 MEXICO NATURAL IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENT SOURCE, 2021-2030 (USD MILLION)
TABLE 240 MEXICO NUTRACEUTICAL EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 241 MEXICO RETAIL SALES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
Lista de Figura
FIGURE 1 NORTH AMERICA PHARMACEUTICAL EXCIPIENTS MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: MULTIVARIATE MODELLING
FIGURE 7 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 10 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: SEGMENTATION
FIGURE 12 INCREASING AWARENESS REGARDING NUTRACEUTICAL APPLICATIONS IS DRIVING THE NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET IN THE FORECAST PERIOD OF 2023 TO 2030
FIGURE 13 THE BINDERS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET IN 2023 & 2030
FIGURE 14 VALUE CHAIN OF NORTH AMERICA NUTRACEUTICAL EXCIPIENT MARKET
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET
FIGURE 16 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY TYPE, 2022
FIGURE 17 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY TYPE, 2023-2030 (USD MILLION)
FIGURE 18 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY TYPE, CAGR (2023-2030)
FIGURE 19 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY TYPE, LIFELINE CURVE
FIGURE 20 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY END PRODUCTS, 2022
FIGURE 21 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY END PRODUCTS, 2023-2030 (USD MILLION)
FIGURE 22 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY END PRODUCTS, CAGR (2023-2030)
FIGURE 23 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY END PRODUCTS, LIFELINE CURVE
FIGURE 24 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY FORM, 2022
FIGURE 25 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY FORM, 2023-2030 (USD MILLION)
FIGURE 26 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY FORM, CAGR (2023-2030)
FIGURE 27 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY FORM, LIFELINE CURVE
FIGURE 28 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY EXCIPIENT SOURCE, 2022
FIGURE 29 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY EXCIPIENT SOURCE, 2023-2030 (USD MILLION)
FIGURE 30 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY EXCIPIENT SOURCE, CAGR (2023-2030)
FIGURE 31 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY EXCIPIENT SOURCE, LIFELINE CURVE
FIGURE 32 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 33 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 34 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 35 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 36 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: SNAPSHOT (2022)
FIGURE 37 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY COUNTRY (2022)
FIGURE 38 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY COUNTRY (2023 & 2030)
FIGURE 39 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY COUNTRY (2022 & 2030)
FIGURE 40 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY TYPE (2023-2030)
FIGURE 41 NORTH AMERICA NUTRACEUTICAL EXCIPIENT MARKET: COMPANY SHARE 2022 (%)
Metodologia de Investigação
A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.
A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.
Personalização disponível
A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.
